Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT00057317. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-blind, Placebo-controlled Dose-ranging Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the study is to determine the dose(s) of Ro 205-2349 which, when compared to placebo, are efficacious, safe and tolerable in improving glycemic control in patients with type 2 diabetes. Doses of 5 to 20 mg/day will be studied.
Study identification
- NCT ID
- NCT00057317
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 35 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2001
- Primary completion
- Nov 30, 2003
- Completion
- Nov 30, 2003
- Last update posted
- Aug 23, 2016
2001 – 2003
United States locations
- U.S. sites
- 65
- U.S. states
- 28
- U.S. cities
- 60
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | 35801 | — |
| Not listed | Mesa | Arizona | 85206 | — |
| Not listed | Scottsdale | Arizona | 85251 | — |
| Not listed | Tucson | Arizona | 85710 | — |
| Not listed | Tucson | Arizona | 85723 | — |
| Not listed | Encino | California | 91436 | — |
| Not listed | Fountain Valley | California | 92708 | — |
| Not listed | Fremont | California | 94538 | — |
| Not listed | Fresno | California | 93720 | — |
| Not listed | Irvine | California | 92618 | — |
| Not listed | Modesto | California | 95355 | — |
| Not listed | Pasadena | California | 91106 | — |
| Not listed | San Bruno | California | 94066 | — |
| Not listed | Santa Rosa | California | 95405 | — |
| Not listed | Sunnyvale | California | 94086 | — |
| Not listed | Hamden | Connecticut | 06518 | — |
| Not listed | Norwalk | Connecticut | 06850 | — |
| Not listed | Newark | Delaware | 19713 | — |
| Not listed | Hollywood | Florida | 33021 | — |
| Not listed | Jacksonville | Florida | 32204 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Atlanta | Georgia | 30322 | — |
| Not listed | Lawrenceville | Georgia | 30045 | — |
| Not listed | Honolulu | Hawaii | 96813 | — |
| Not listed | Indianapolis | Indiana | 46214-2985 | — |
| Not listed | Overland Park | Kansas | 66211 | — |
| Not listed | New Orleans | Louisiana | 70121 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Kansas City | Missouri | 64111 | — |
| Not listed | St Louis | Missouri | 63104 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Billings | Montana | 59101 | — |
| Not listed | Omaha | Nebraska | 68198-3032 | — |
| Not listed | Las Vegas | Nevada | 89102 | — |
| Not listed | Trenton | New Jersey | 08611 | — |
| Not listed | Albuquerque | New Mexico | 87106 | — |
| Not listed | Buffalo | New York | 14209 | — |
| Not listed | New Hyde Park | New York | 11040 | — |
| Not listed | Rochester | New York | 14609 | — |
| Not listed | Charlotte | North Carolina | 28209 | — |
| Not listed | Durham | North Carolina | 27710 | — |
| Not listed | Greenville | North Carolina | 27858-4354 | — |
| Not listed | Morrisville | North Carolina | 27560 | — |
| Not listed | Portland | Oregon | 97201 | — |
| Not listed | Tualatin | Oregon | 97062 | — |
| Not listed | Camp Hill | Pennsylvania | 17011 | — |
| Not listed | Connellsville | Pennsylvania | 15425 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Philadelphia | Pennsylvania | 19107 | — |
| Not listed | East Providence | Rhode Island | 02914 | — |
| Not listed | Greer | South Carolina | 29651 | — |
| Not listed | Memphis | Tennessee | 38119 | — |
| Not listed | Dallas | Texas | 75230 | — |
| Not listed | El Paso | Texas | 79902 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Midland | Texas | 79705 | — |
| Not listed | San Antonio | Texas | 78229-4801 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | San Antonio | Texas | 78284 | — |
| Not listed | Lebanon | Virginia | 24266 | — |
| Not listed | Richmond | Virginia | 23294 | — |
| Not listed | Virginia Beach | Virginia | 23451 | — |
| Not listed | Edmonds | Washington | 98026 | — |
| Not listed | Wenatchee | Washington | 98801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00057317, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2016 · Synced Sep 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00057317 live on ClinicalTrials.gov.